Camber Spine Diagon Oblique Cage
by Camber Spine
510(k) K134038
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK134038 | Date20 Mar 2014 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- MAX
- Device Class
- Class II
- Regulation
- 21 CFR Part 888.3080
- Advisory Committee
- Orthopedic
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 24 Sep 2026
The Camber Spine Diagon Oblique Cage is an intervertebral body fusion device designed for use in the lumbar spine. It is indicated for intervertebral body fusion procedures in skeletally mature patients diagnosed with degenerative disc disease at one or two contiguous levels from L2-S1.
This device has received FDA 510(k) clearance. It is intended for patients with discogenic pain and disc degeneration confirmed by history and radiographic studies, including those with up to Grade I spondylolisthesis.
Other devices from Camber Spine
Questions
AI-generated answers, 24 Sep 2026
What is the intended use of the Camber Spine Diagon Oblique Cage?
This device is an intervertebral body fusion cage designed for use in the lumbar spine. It is specifically indicated for fusion procedures in skeletally mature patients suffering from degenerative disc disease at one or two contiguous levels between L2 and S1.
Which patient conditions are suitable for this fusion device?
The cage is intended for patients who have confirmed discogenic pain and disc degeneration based on patient history and radiographic studies. It is also indicated for use in patients with up to Grade I spondylolisthesis.
Has this device received regulatory clearance?
Yes, the Camber Spine Diagon Oblique Cage has received FDA 510(k) clearance. This indicates that the device has been reviewed and determined to be substantially equivalent to legally marketed predicate devices.